Balyasny Asset Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-11,995	Closed	-$275K	–	2004
2018 Q1	$275K	Sell	11,995 -2,570	-18%	-$58.9K	﹤0.01%	1453
2017 Q4	$377K	Buy	14,565 +3,000	+26%	+$77.7K	﹤0.01%	1402
2017 Q3	$171K	Buy	+11,565	New	+$171K	﹤0.01%	1522